Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Anesthesiology Guidelines
    • French Society of...

    French Society of Anesthesia guidelines on postoperative pain management

    Written by Hina Zahid Published On 2019-06-25T19:00:36+05:30  |  Updated On 12 Aug 2021 5:17 PM IST

    The French Society of Anesthesia and Intensive Care Medicine (SFAR) have published experts' guidelines on the care of postoperative pain. This is an update of the 2008 guidelines.


    In all fourteen experts analysed the literature (PubMed™, Cochrane™) on questions that had not been treated in the previous guidelines, or to modify the guidelines following new data in the published literature. Seventeen recommendations were formalised on the assessment of perioperative pain, and most particularly in non-communicating patients, on opioid and non-opioid analgesics and on anti-hyperalgesic drugs, such as ketamine and gabapentinoids, as well as on local and regional anaesthesia. Because of the absence of sufficient data or new information, no recommendation was made about analgesia monitoring, the procedures for the surveillance of patients in conventional care structures, or perinervous or epidural catheterism.


    Following are the major recommendations:




    • During the preoperative period, we recommend identifying the most vulnerable patients to pain (with risks to develop severe postoperative pain and/or a chronic post-surgical pain (CPSP)) by focusing on preoperative pain, including pain even far from the operating site, the long-term consumption of opioids, and surgical and psychological factors such as anxiety or depression.

    • We recommend using the APAIS scale (Amsterdam Preoperative Anxiety and Information Scale) as measure anxiety and/or the need for information during the preoperative period.

    • We recommend identifying the postoperative risk factors for CPSP by searching a high intensity of POP (using a numerical scale), an uncommon prolongation of POP, an early neuropathic pain (using a DN4 scale), or signs of anxiety or depression.

    • We recommend using a self-assessment scale from 5 years old (face scale, Appendix 1). Otherwise, we recommend using the FLACC scale for postoperative pain assessment in children under 7 years of age (Appendix 2).

    • For communicant patients, we recommend using a modified FLACC scale in children, and ALGOPLUS in elderly people.

    • We recommend the association of a non-selective NSAID (NS-NSAID) or a selective inhibitor of type 2 cyclooxygenase (ISCOX2) with morphine if there is no contraindication to the use of NSAIDs.

    • We do not recommend using a type-2 inhibitor of cyclooxygenases (ISCOX2) in patients with a history of atherothrombosis (PAD (peripheral artery disease), stroke, myocardial infarction).

    • We do not recommend administering NS-NSAIDs in patients atherothrombosis (PAD (peripheral artery disease), stroke, myocardial infarction) for more than 7 days

    • We do not recommend associating NS-NSAIDs with curative doses of the anticoagulant.

    • We recommend to prescribe a strong opiate (morphine or oxycodone), ideally through oral route, for severe postoperative pain or if weaker analgesics are not powerful enough to relief the patients. This recommendation applies to all ages.

    • We suggest that adults who undergo major surgery (abdominal, pelvic or spinal surgeries) and who do not benefit regional analgesia receive intravenous lidocaine infusion (bolus: 1 to 2 mg/kg followed by 1 to 2 mg/kg/h) in order to decrease the level of postoperative pain and to improve recovery.

    • We suggest that adults receive dexamethasone IV at 8 mg to reduce postoperative pain.

    • Intraoperatively, small doses of ketamine in patients on general anaesthesia are recommended in the two following situations: 1/ surgery with high risk of acute pain or chronic postoperative pain; 2/ patients with vulnerability to pain, and most particularly patients taking long-term opioids or addicted to opioids.

    • The systematic use of gabapentinoids preoperatively is not recommended for postoperative pain management.

    • It is recommended not to exceed the maximal toxic doses of local anaesthetics, most specifically for peri-prosthetic orthopaedic infiltrations and during associations of scar infiltrations and perinervous analgesic catheters.

    • In case of laparotomy (laparotomy, caesarean section and lumbotomy), and in the absence of epidural analgesia, we probably recommend the implementation of a continuous infiltration catheter.

    • We do not recommend performing an analgesic infiltration using an intra-articular catheter because of the toxic risk of local anaesthetics on cartilage.

    depressionFrench Society of Anaesthesia and Intensive Care MedicinegabapentinoidsKetamineMedical newsmedical news indiamyocardial infarctionNSAIDsopioidspostoperative painpreoperative periodSFARvulnerable patients

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok